West Pharmaceutical Services, Inc.
WSTHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeWest Pharmaceutical Services, Inc. operates in the Medical Instruments & Supplies space. West Pharmaceutical Services, Inc. The $23.93B market capitalization puts WST squarely in large-cap range for its industry. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Market Cap
$23.93B
Beta
1.14
P/E (TTM)
43.87
P/E (Fwd)
34.12
EPS (TTM)
$7.75
EPS (Fwd)
$9.96
ROE
19.1%
ROA
11.4%
Cash
$435.8M
Total Debt
$316.5M
Free CF
$277.9M
52W Change
36.7%
Annual Financials
Cash vs Debt
Where WST stands vs its 150-day and 200-day moving averages
As of the August 31, 2026 close, WST finished 12.95% above its 150-day moving average ($298.79) and 15.74% above its 200-day moving average ($291.57). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is WST overbought or oversold?
At the August 31, 2026 close, WST's RSI(14) was 32.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
West Pharmaceutical Services, Inc. holds $435.8M in cash against $316.5M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $277.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 19.1%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 11.4% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $2.89B (2022) to $3.07B (2025).
Investors considering West Pharmaceutical Services, Inc. should weigh the typical risks associated with WST's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence West Pharmaceutical Services, Inc.'s trajectory.